PUBLISHER: IMARC | PRODUCT CODE: 1541733
PUBLISHER: IMARC | PRODUCT CODE: 1541733
Malaria Diagnostics Market Report by Technology (Microscopy, Rapid Diagnostic Tests (RDTs), Molecular Diagnostic Tests), End Use (Hospital, Clinics, Diagnostic Centers), and Region 2024-2032
The global malaria diagnostics market size reached US$ 829.3 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 1,383.3 Million by 2032, exhibiting a growth rate (CAGR) of 5.7% during 2024-2032.
Malaria diagnostics refers to the clinical tests conducted to detect the presence of the infection in individuals. Malaria is caused by the bite of an infected female Anopheles mosquito, which leads to the transfer of Plasmodium parasites into the body. Some common symptoms include fever, fatigue, nausea and headaches. The infection is diagnosed through various rapid diagnostics, microscopy and molecular diagnostic tests. These tests use antigen detection and serology techniques using indirect immunofluorescence (IFA) or enzyme-linked immunosorbent assay (ELISA). They are widely used in hospitals, laboratories, clinics, research institutes and diagnostic centers.
Malaria Diagnostics Market Trends:
The increasing prevalence of malaria across the globe is one of the key factors creating a positive outlook for the market. Malaria is a life-threatening infection that has caused a significant loss of human lives, especially in developing nations. However, rising awareness among the masses regarding the available diagnostic and treatment alternatives for malaria is providing a thrust to the market growth. Healthcare centers and diagnostic laboratories are widely adopting microscopic diagnostics to identify the parasite at different stages and design suitable treatment plans. Additionally, various technological advancements, such as the development of the Quantitative Buffy Coat (QBC) method and peripheral blood smear technique for diagnosing malaria, are acting as other growth-inducing factors. In line with this, the availability of Point-of-Care (POC) diagnostic devices for enhanced accuracy is also contributing to the growth of the market. Other factors, including rising healthcare expenditure capacities of the masses, along with the implementation of favorable government policies promoting public health, are anticipated to drive the market toward growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global malaria diagnostics market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on technology and end use.
Breakup by Technology:
Microscopy
Rapid Diagnostic Tests (RDTs)
Molecular Diagnostic Tests
Conventional PCR
Real-Time PCR (qPCR)
Breakup by End Use:
Hospital
Clinics
Diagnostic Centers
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Access Bio, Beckman Coulter Inc. (Danaher Corporation), bioMerieux SA (Compagnie Merieux Alliance), Bio-Rad Laboratories Inc., Nikon Corporation, Novartis AG, Olympus Corporation, Premier Medical Corporation Pvt. Ltd., Siemens Healthcare GmbH (Siemens AG), Sysmex Corporation and Thermo Fisher Scientific Inc.
Key Questions Answered in This Report
- 1. How big is the global malaria diagnostics market?
- 2. What is the expected growth rate of the global malaria diagnostics market during 2024-2032?
- 3. What are the key factors driving the global malaria diagnostics market?
- 4. What has been the impact of COVID-19 on the global malaria diagnostics market?
- 5. What is the breakup of the global malaria diagnostics market based on the technology?
- 6. What is the breakup of the global malaria diagnostics market based on the end use?
- 7. What are the key regions in the global malaria diagnostics market?
- 8. Who are the key players/companies in the global malaria diagnostics market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Malaria Diagnostics Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Technology
- 6.1 Microscopy
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Rapid Diagnostic Tests (RDTs)
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Molecular Diagnostic Tests
- 6.3.1 Market Trends
- 6.3.2 Key Segments
- 6.3.2.1 Conventional PCR
- 6.3.2.2 Real-Time PCR (qPCR)
- 6.3.3 Market Forecast
7 Market Breakup by End Use
- 7.1 Hospital
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Clinics
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Diagnostic Centers
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
8 Market Breakup by Region
- 8.1 North America
- 8.1.1 United States
- 8.1.1.1 Market Trends
- 8.1.1.2 Market Forecast
- 8.1.2 Canada
- 8.1.2.1 Market Trends
- 8.1.2.2 Market Forecast
- 8.1.1 United States
- 8.2 Asia-Pacific
- 8.2.1 China
- 8.2.1.1 Market Trends
- 8.2.1.2 Market Forecast
- 8.2.2 Japan
- 8.2.2.1 Market Trends
- 8.2.2.2 Market Forecast
- 8.2.3 India
- 8.2.3.1 Market Trends
- 8.2.3.2 Market Forecast
- 8.2.4 South Korea
- 8.2.4.1 Market Trends
- 8.2.4.2 Market Forecast
- 8.2.5 Australia
- 8.2.5.1 Market Trends
- 8.2.5.2 Market Forecast
- 8.2.6 Indonesia
- 8.2.6.1 Market Trends
- 8.2.6.2 Market Forecast
- 8.2.7 Others
- 8.2.7.1 Market Trends
- 8.2.7.2 Market Forecast
- 8.2.1 China
- 8.3 Europe
- 8.3.1 Germany
- 8.3.1.1 Market Trends
- 8.3.1.2 Market Forecast
- 8.3.2 France
- 8.3.2.1 Market Trends
- 8.3.2.2 Market Forecast
- 8.3.3 United Kingdom
- 8.3.3.1 Market Trends
- 8.3.3.2 Market Forecast
- 8.3.4 Italy
- 8.3.4.1 Market Trends
- 8.3.4.2 Market Forecast
- 8.3.5 Spain
- 8.3.5.1 Market Trends
- 8.3.5.2 Market Forecast
- 8.3.6 Russia
- 8.3.6.1 Market Trends
- 8.3.6.2 Market Forecast
- 8.3.7 Others
- 8.3.7.1 Market Trends
- 8.3.7.2 Market Forecast
- 8.3.1 Germany
- 8.4 Latin America
- 8.4.1 Brazil
- 8.4.1.1 Market Trends
- 8.4.1.2 Market Forecast
- 8.4.2 Mexico
- 8.4.2.1 Market Trends
- 8.4.2.2 Market Forecast
- 8.4.3 Others
- 8.4.3.1 Market Trends
- 8.4.3.2 Market Forecast
- 8.4.1 Brazil
- 8.5 Middle East and Africa
- 8.5.1 Market Trends
- 8.5.2 Market Breakup by Country
- 8.5.3 Market Forecast
9 SWOT Analysis
- 9.1 Overview
- 9.2 Strengths
- 9.3 Weaknesses
- 9.4 Opportunities
- 9.5 Threats
10 Value Chain Analysis
11 Porters Five Forces Analysis
- 11.1 Overview
- 11.2 Bargaining Power of Buyers
- 11.3 Bargaining Power of Suppliers
- 11.4 Degree of Competition
- 11.5 Threat of New Entrants
- 11.6 Threat of Substitutes
12 Price Analysis
13 Competitive Landscape
- 13.1 Market Structure
- 13.2 Key Players
- 13.3 Profiles of Key Players
- 13.3.1 Abbott Laboratories
- 13.3.1.1 Company Overview
- 13.3.1.2 Product Portfolio
- 13.3.1.3 Financials
- 13.3.1.4 SWOT Analysis
- 13.3.2 Access Bio
- 13.3.2.1 Company Overview
- 13.3.2.2 Product Portfolio
- 13.3.2.3 Financials
- 13.3.3 Beckman Coulter Inc. (Danaher Corporation)
- 13.3.3.1 Company Overview
- 13.3.3.2 Product Portfolio
- 13.3.3.3 SWOT Analysis
- 13.3.4 bioMerieux SA (Compagnie Merieux Alliance)
- 13.3.4.1 Company Overview
- 13.3.4.2 Product Portfolio
- 13.3.4.3 Financials
- 13.3.4.4 SWOT Analysis
- 13.3.5 Bio-Rad Laboratories Inc.
- 13.3.5.1 Company Overview
- 13.3.5.2 Product Portfolio
- 13.3.5.3 Financials
- 13.3.5.4 SWOT Analysis
- 13.3.6 Nikon Corporation
- 13.3.6.1 Company Overview
- 13.3.6.2 Product Portfolio
- 13.3.6.3 Financials
- 13.3.6.4 SWOT Analysis
- 13.3.7 Novartis AG
- 13.3.7.1 Company Overview
- 13.3.7.2 Product Portfolio
- 13.3.7.3 Financials
- 13.3.7.4 SWOT Analysis
- 13.3.8 Olympus Corporation
- 13.3.8.1 Company Overview
- 13.3.8.2 Product Portfolio
- 13.3.8.3 Financials
- 13.3.8.4 SWOT Analysis
- 13.3.9 Premier Medical Corporation Pvt. Ltd.
- 13.3.9.1 Company Overview
- 13.3.9.2 Product Portfolio
- 13.3.10 Siemens Healthcare GmbH (Siemens AG)
- 13.3.10.1 Company Overview
- 13.3.10.2 Product Portfolio
- 13.3.10.3 Financials
- 13.3.10.4 SWOT Analysis
- 13.3.11 Sysmex Corporation
- 13.3.11.1 Company Overview
- 13.3.11.2 Product Portfolio
- 13.3.11.3 Financials
- 13.3.11.4 SWOT Analysis
- 13.3.12 Thermo Fisher Scientific Inc
- 13.3.12.1 Company Overview
- 13.3.12.2 Product Portfolio
- 13.3.12.3 Financials
- 13.3.12.4 SWOT Analysis
- 13.3.1 Abbott Laboratories
List of Figures
- Figure 1: Global: Malaria Diagnostics Market: Major Drivers and Challenges
- Figure 2: Global: Malaria Diagnostics Market: Sales Value (in Million US$), 2018-2023
- Figure 3: Global: Malaria Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 4: Global: Malaria Diagnostics Market: Breakup by Technology (in %), 2023
- Figure 5: Global: Malaria Diagnostics Market: Breakup by End Use (in %), 2023
- Figure 6: Global: Malaria Diagnostics Market: Breakup by Region (in %), 2023
- Figure 7: Global: Malaria Diagnostics (Microscopy) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 8: Global: Malaria Diagnostics (Microscopy) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 9: Global: Malaria Diagnostics (Rapid Diagnostic Tests (RDTs)) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 10: Global: Malaria Diagnostics (Rapid Diagnostic Tests (RDTs)) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 11: Global: Malaria Diagnostics (Molecular Diagnostic Tests) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 12: Global: Malaria Diagnostics (Molecular Diagnostic Tests) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 13: Global: Malaria Diagnostics (Hospital) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 14: Global: Malaria Diagnostics (Hospital) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 15: Global: Malaria Diagnostics (Clinics) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 16: Global: Malaria Diagnostics (Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 17: Global: Malaria Diagnostics (Diagnostic Centers) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 18: Global: Malaria Diagnostics (Diagnostic Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 19: North America: Malaria Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 20: North America: Malaria Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 21: United States: Malaria Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 22: United States: Malaria Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 23: Canada: Malaria Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 24: Canada: Malaria Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 25: Asia-Pacific: Malaria Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 26: Asia-Pacific: Malaria Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 27: China: Malaria Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 28: China: Malaria Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 29: Japan: Malaria Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 30: Japan: Malaria Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 31: India: Malaria Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 32: India: Malaria Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 33: South Korea: Malaria Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 34: South Korea: Malaria Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 35: Australia: Malaria Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 36: Australia: Malaria Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 37: Indonesia: Malaria Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 38: Indonesia: Malaria Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 39: Others: Malaria Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 40: Others: Malaria Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 41: Europe: Malaria Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 42: Europe: Malaria Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 43: Germany: Malaria Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 44: Germany: Malaria Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 45: France: Malaria Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 46: France: Malaria Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 47: United Kingdom: Malaria Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 48: United Kingdom: Malaria Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 49: Italy: Malaria Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 50: Italy: Malaria Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 51: Spain: Malaria Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 52: Spain: Malaria Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 53: Russia: Malaria Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 54: Russia: Malaria Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 55: Others: Malaria Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 56: Others: Malaria Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 57: Latin America: Malaria Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 58: Latin America: Malaria Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 59: Brazil: Malaria Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 60: Brazil: Malaria Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 61: Mexico: Malaria Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 62: Mexico: Malaria Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 63: Others: Malaria Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 64: Others: Malaria Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 65: Middle East and Africa: Malaria Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 66: Middle East and Africa: Malaria Diagnostics Market: Breakup by Country (in %), 2023
- Figure 67: Middle East and Africa: Malaria Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 68: Global: Malaria Diagnostics Industry: SWOT Analysis
- Figure 69: Global: Malaria Diagnostics Industry: Value Chain Analysis
- Figure 70: Global: Malaria Diagnostics Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Malaria Diagnostics Market: Key Industry Highlights, 2023 and 2032
- Table 2: Global: Malaria Diagnostics Market Forecast: Breakup by Technology (in Million US$), 2024-2032
- Table 3: Global: Malaria Diagnostics Market Forecast: Breakup by End Use (in Million US$), 2024-2032
- Table 4: Global: Malaria Diagnostics Market Forecast: Breakup by Region (in Million US$), 2024-2032
- Table 5: Global: Malaria Diagnostics Market: Competitive Structure
- Table 6: Global: Malaria Diagnostics Market: Key Players
